Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19
NCT04470544
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Severe Acute Respiratory Syndrome
Interventions
DRUG:
Camostat Mesilate
OTHER:
Standard of Care
Sponsor
Alan Bryce